172@29@16@53!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=0&s_cid=0&radar_off=0&is_revamped_header=1&is_responsive=1&sec=&priceinter=1&frommc=1!~!www|moneycontrol|com!~!|commonstore|commonfiles|moneycontrol_header.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
you are here:

Aarti Drugs Ltd.

BSE: 524348 | NSE: AARTIDRUGS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE767A01016 | SECTOR: Pharmaceuticals

BSE Live

Oct 20, 16:00
778.00 5.85 (0.76%)
Volume
AVERAGE VOLUME
5-Day
60,203
10-Day
106,887
30-Day
91,861
74,787
  • Prev. Close

    772.15

  • Open Price

    771.00

760.10

Today’s L/H

805.00
105.56

52 Wk L/H

1025.00
733.55

L/U Price Band

810.75
  • Bid Price (Qty.)

    781.00 (176)

  • Offer Price (Qty.)

    790.00 (2)

  •  VWAP

    790.51
     Beta
    0.72
  • Market Depth (20 Oct 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    176 781.00 783.00 60
    112 780.00 783.90 1
    1 779.60 784.10 2
    2 778.40 784.15 50
    12 777.40 784.60 75
    1431 Total Total 1795
     Market Depth
    BUY 1431.00
    SELL 1795.00
    44%
    56%

NSE Live

Oct 20, 15:59
778.70 6.40 (0.83%)
Volume
AVERAGE VOLUME
5-Day
874,843
10-Day
1,172,927
30-Day
962,558
1,118,913
  • Prev. Close

    772.30

  • Open Price

    776.00

760.00

Today’s L/H

804.90
105.25

52 Wk L/H

3089.00
733.70

L/U Price Band

810.90
  • Bid Price (Qty.)

    778.70 (942)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    789.10
     Beta
    0.73
  • DELIVERY AVERAGES
    3-Day
    46.77%
    5-Day
    42.26%
    8-Day
    33.05%
    Deliverables
  • SMA
    30
    784.18
    50
    741.16
    150
    417.87
    200
    352.45
    SMA
    784.18
Powered by Trendlyne

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Neutral
Moving Averages Neutral
Technical Indicators Neutral
Moving Averages Crossovers Neutral
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 794.80 817.30 829.60 782.50 760.00 747.70 725.20
Fibonacci 795.79 804.01 817.30 782.50 769.21 760.99 747.70
Camarilla 775.49 778.68 781.87 782.50 769.11 765.92 762.73

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 792.11
10 857.94
20 814.07
50 741.16
100 541.47
200 352.45
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

Type R1 R2 R3 PP S1 S2 S3
Classic 883.53 976.77 1033.53 826.77 733.53 676.77 583.53
Fibonacci 884.07 919.47 976.77 826.77 769.47 734.07 676.77
Camarilla 804.05 817.80 831.55 826.77 776.55 762.80 749.05

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 812.37 853.43 934.62 731.18 690.12 608.93 567.87
Fibonacci 777.88 806.73 853.43 731.18 684.48 655.63 608.93
Camarilla 782.51 793.71 804.92 731.18 760.09 748.89 737.68

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      7,250.96
    • P/E
      38.78
    • Book Value (Rs)
      66.72
    • Dividend (%)
      20.00
    • Market Lot
      1
    • Industry P/E
      36.64
    • EPS (TTM)
      20.08
    • P/C
      31.04
    • Price/Book
      11.66
    • Dividend Yield.(%)
      0.26
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      46.77
      5-Day
      42.26
      8-Day
      33.05
      53.47

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      7,250.96
    • P/E
      35.51
    • Book Value (Rs)
      70.01
    • Dividend (%)
      20.00
    • Market Lot
      1
    • Industry P/E
      36.64
    • EPS (TTM)
      21.93
    • P/C
      28.65
    • Price/Book
      11.11
    • Dividend Yield.(%)
      0.26
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      46.77
      5-Day
      42.26
      8-Day
      33.05
      53.47

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

  • 100% BUY
  • 0% SELL
  • 0% HOLD
100%
of moneycontrol users recommend buying Aarti Drugs

What's your call on Aarti Drugs today?

Read 75 investor views

BUY SELL HOLD

Action in Aarti Drugs Ltd.

  • Only Sellers

    Only Sellers in Aarti Drugs on NSE

    Oct 12, 10:15

  • Only Buyers

    Only Buyers in Aarti Drugs on NSE

    Oct 07, 13:35

  • Only Buyers

    Only Buyers in Aarti Drugs on NSE

    Oct 06, 10:05

  • Only Buyers

    Only Buyers in Aarti Drugs on NSE

    Oct 05, 10:05

  • Only Buyers

    Only Buyers in Aarti Drugs on NSE

    Oct 01, 10:05

  • Only Buyers

    Only Buyers in Aarti Drugs on NSE

    Sep 30, 10:05

  • Bonus

    Aarti Drugs Bonus, Bonus Ratio 3:1, Record date: Oct 01, 2020, Ex-Bonus: Sep 30, 2020

    Sep 29, 11:00

  • Technicals

    Aarti Drugs closes above 30-Day Moving Average of 2871.25 today.

    Sep 25

  • Technicals

    Aarti Drugs closes below 30-Day Moving Average of 2843.39 today.

    Sep 24

  • AGM/EGM

    Aarti Drugs AGM on Sep 25, 2020, Announcement date: Jul 31, 2020

    Sep 24, 11:00

  • AGM/EGM

    Aarti Drugs POM on Sep 22, 2020, Announcement date: Aug 21, 2020

    Sep 21, 11:00

  • Only Buyers

    Only Buyers in Aarti Drugs on NSE

    Sep 02, 13:35

  • Only Buyers

    Only Buyers in Aarti Drugs on NSE

    Sep 01, 15:20

  • Only Sellers

    Only Sellers in Aarti Drugs on NSE

    Aug 26, 15:10

  • Only Buyers

    Only Buyers in Aarti Drugs on NSE

    Aug 24, 13:00

  • AGM/EGM

    Aarti Drugs AGM on Aug 25, 2020, Announcement date: Jul 31, 2020

    Aug 24, 11:00

  • Only Buyers

    Only Buyers in Aarti Drugs on NSE

    Aug 21, 11:20

  • News

    Aarti Drugs’ API business gains as pharma firms diversify raw material sourcing from China

    Jul 30, 20:00

  • Views

    Buy Aarti Drugs; target of Rs 1028: Anand Rathi

    May 20, 16:30

  • Technicals

    Aarti Drugs closes above its 30-Day,50-Day,150-Day Moving Average today.

    Apr 07

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Oct 21, 09:15
771.00 -1.15 (-0.15%)
High 805.65
Low 771.00
Prev. Close 772.15

NSE

Oct 21, 09:15
776.00 3.70 (0.48%)
High 776.00
Low 776.00
Prev. Close 772.30

Financials

(Rs. Cr)
Quarterly JUN 2020 MAR 2020 DEC 2019 SEP 2019 JUN 2019
Sales
544 449 473 477 405
Other Income
1 0 0 0 0
Total Income
545 450 473 477 405
Total Expenditure
423 382 422 421 362
EBIT
122 68 51 56 42
Interest
6 7 8 8 9
Tax
30 1 15 15 11
Net Profit
85 58 27 32 22

Historical Prices

On
Current Price %Gain / Loss
Open Price 112.75 771.00
583.81
High Price 114.06 805.00
605.77
Low Price 112.00 760.10
578.66
Close Price 113.99 772.15
577.38
Volume 2,644 74,787
2728.56
On
Current Price %Gain / Loss
Open Price 112.00 776.00
592.86
High Price 114.11 804.90
605.37
Low Price 111.96 760.00
578.81
Close Price 114.00 772.30
577.46
Volume 18,216 1,118,913
6042.47
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11896.80 23.80 0.20
SENSEX 40544.37 112.77 0.28
NIFTY BANK 24311.80 45.05 0.19
NIFTY IT 21694.35 302.45 1.41
S&P BSE Smallcap 14896.14 45.26 0.30
Index Price Change %Chg
Nasdaq (Oct 21) 11,516.49 37.61 0.33
FTSE (Oct 20) 5,889.22 4.57 0.08
DAX (Oct 20) 12,736.95 -117.71 -0.92
CAC (Oct 20) 4,929.28 -13.34 -0.27
SGX Nifty (Oct 21) 11,913.50 6.00 0.05

CORPORATE ACTION

Date Agenda
Aug 20, 2020 Bonus issue
Jul 25, 2020 Quarterly Results
May 15, 2020 Audited Results
Feb 06, 2020 Quarterly Results & Interim Dividend
Oct 23, 2019 Audited Results
Type Dividend% Ex-Dividend date
Interim 20.00 Feb 17, 2020
Final 10.00 Jul 26, 2019
Final 10.00 Aug 01, 2018
Final 10.00 Aug 09, 2017
Interim 30.00 Mar 22, 2016
Ratio Announcement Date Ex-Bonus
3:1 Aug 20, 2020 Sep 30, 2020
1:1 Jan 30, 2015 Mar 24, 2015
1:2 Jan 15, 1996 May 13, 1996
Old FV New FV Ex-Split
No Splits Information is available for Aarti Drugs
Ratio Premium Ex-Bonus
No Rights Information is available for Aarti Drugs
Date Agenda
Sep 22, 2020 -
Sep 25, 2020 -
Aug 06, 2019 -
Mar 29, 2019 Buy Back of Shares
Mar 22, 2019 -

Dividend Summary

For the year ending March 2020 Aarti Drugs has declared an equity dividend of 20.00% amounting to Rs 2 per share. At the current share price of Rs 778.70 this results in a dividend yield of 0.26%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone October 2020 March 2020 March 2019 December 2018
Promoters 60.21 61.44 62.26 62.3
Pledged 0 0 0 0
FII/FPI 2.19 1.07 0.5 0.44
Total DII 6.08 8.82 7.94 8.71
Fin.Insts 0 0.11 0.01 0.07
Insurance Co 0 0 0 0
MF 1.85 4.19 4.06 4.03
Others DIIs 4.23 4.52 3.87 4.61
Others 31.52 28.67 29.29 28.55
Total 100 100 99.99 100

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Aarti Drugs 778.00 0.76 1025.00 105.56 7250.96 1,634.92 135.67
Sun Pharma 486.40 0.58 564.90 315.20 116703.65 12,531.93 3,211.14
Dr Reddys Labs 5069.35 0.35 5514.65 2497.60 84287.72 11,850.40 2,937.70
Divis Labs 3086.95 -0.19 3388.00 1627.15 81948.82 5,310.57 1,372.71
Cipla 764.05 0.03 829.00 356.75 61610.38 12,659.15 2,318.17

COMPANY OVERVIEW

Aarti Drugs Ltd. is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. They manufacture drugs in therapeutic segments such as anti-arthritis, anti-fungal, antibiotics, anti-diabetic, anti-cholinergic, sedatives, anti-depressant, anti-diarrhea and anti-inflammatory. Their product list includes active pharmaceuticals ingredients (API) and steroids , pharma intermediates for irbesartan, Zolpidem Tartrate, Tamsulosin HCL, Leflunomide and Levocetirizine, Speciality Chemicals such as benzene sulphonyl chloride, benzene sulphonamide, diphenyl sulphone, N-ethyl toluene sulphonamide, ethyl toluene sulphonate, para chloro benzene sulphonamide, benzene sulfonyl hydrazide and many more. R&D programs of the company is focused on new products amongest non-steroidal NSAID compounds, antiparasitic, calciun antagonist, antianginal, antidiabetics, antdepressant and many more. The company has also planned to work on agro chemicals.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Chandrakant V Gogri

      Chairman Emeritus

    • Prakash M Patil

      Chairman & M.D & CEO

    • Rashesh C Gogri

      Managing Director

    • Harshit M Savla

      Joint Managing Director

    • Harit P Shah

      Whole Time Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Aarti Drugs Ltd.

Aarti Drugs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 524348 and the NSE with an NSE Code of AARTIDRUGS.

Related Searches